第一单位：
Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
作者：
Simon,Schallenberg [1]
;
Gabriel,Dernbach [2]
;
Sharon,Ruane [3]
;
Philipp,Jurmeister [4]
;
Cornelius,Böhm [3]
;
Kai,Standvoss [3]
;
Sandip,Ghosh [3]
;
Marco,Frentsch [5]
;
Mihnea P,Dragomir [6]
;
Philipp G,Keyl [7]
;
Corinna,Friedrich [8]
;
Il-Kang,Na [9]
;
Sabine,Merkelbach-Bruse [10]
;
Alexander,Quaas [10]
;
Nikolaj,Frost [11]
;
Kyrill,Boschung [12]
;
Winfried,Randerath [12]
;
Georg,Schlachtenberger [13]
;
Matthias,Heldwein [13]
;
Ulrich,Keilholz [14]
;
Khosro,Hekmat [13]
;
Jens-Carsten,Rückert [15]
;
Reinhard,Büttner [10]
;
Angela,Vasaturo [16]
;
David,Horst [1]
;
Lukas,Ruff [3]
;
Maximilian,Alber [2]
;
Klaus-Robert,Müller [17]
;
Frederick,Klauschen [18]
作者单位：
Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
[1]
Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.;Aignostics, Berlin, Germany.
[2]
Aignostics, Berlin, Germany.
[3]
Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany.
[4]
Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.;BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
[5]
Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.;German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.;Berlin Institute of Health (BIH), Berlin, Germany.
[6]
BIFOLD - Berlin Institute for the Foundations of Learning and Data, Berlin, Germany.
[7]
Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.;Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Proteomics Platform, Berlin, Germany.
[8]
Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.;BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.;German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.;ECRC Experimental and Clinical Research Center, Charite - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
[9]
Institute of Pathology, University Hospital Cologne, Köln, Germany.
[10]
Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
[11]
Bethanien Hospital, Clinic of Pneumology and Allergology, Center for Sleep Medicine and Respiratory Care, Institute of Pneumology at the University of Cologne, Solingen, Germany.
[12]
Department of Cardiothoracic Surgery, University Hospital Cologne, Solingen, Germany.
[13]
Berlin Institute of Health (BIH), Berlin, Germany.;Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
[14]
Department of General, Visceral, Vascular and Thoracic Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.
[15]
Ultivue, Berlin, Germany.
[16]
BIFOLD - Berlin Institute for the Foundations of Learning and Data, Berlin, Germany. klaus-robert.mueller@tu-berlin.de.;Machine Learning Group, Technische Universität Berlin, Berlin, Germany. klaus-robert.mueller@tu-berlin.de.;Max-Planck-Institute for Informatics, Saarbrücken, Germany. klaus-robert.mueller@tu-berlin.de.;Department of Artificial Intelligence, Korea University, Seoul, South Korea. klaus-robert.mueller@tu-berlin.de.
[17]
Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany. frederick.klauschen@med.uni-muenchen.de.;Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany. frederick.klauschen@med.uni-muenchen.de.;BIFOLD - Berlin Institute for the Foundations of Learning and Data, Berlin, Germany. frederick.klauschen@med.uni-muenchen.de.;German Cancer Consortium (DKTK), partner site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Germany. frederick.klauschen@med.uni-muenchen.de.;Bavarian Cancer Research Center (BZKF), Munich, Germany. frederick.klauschen@med.uni-muenchen.de.
[18]
DOI
10.1038/s41467-025-65783-z
PMID
41184299
发布时间
2025-11-03
换一批
